Malignant serous effusion (MSE) is a common and severe complication in advanced malignancies, associated with poor prognosis and high recurrence rates. To date, no standardized treatments are available for MSE management, posing significant clinical challenges. Here, we identify aberrant LIN28B expr...
ORGANISM(S): Homo sapiens